Programming

Vascular Discovery: from Genes to Medicine Scientific Sessions 2020

May 5–7, 2020
Hilton Chicago | Chicago, IL

About This Meeting

Vascular Discovery: From Genes to Medicine is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology and the Peripheral Vascular Disease Council, in cooperation with the Council on Genomic and Precision Medicine, and the Society for Vascular Surgery. This meeting provides unique opportunities to meet with colleagues from around the world with wide-ranging research interests and expertise within the research communities of arteriosclerosis, thrombosis, vascular biology. The primary goal of this conference is to provide a forum for the timely exchange of information about new and emerging scientific research in lipids and lipoproteins, arteriosclerosis, thrombosis, vascular biology, genomics and peripheral vascular disease.

One of the areas of emphasis for this conference is to encourage interactions between young scientists and more senior scientists in their research area to foster dialogue and facilitate the exchange of ideas. The format of the conference, with many invited presentations as well as a dedicated focus on poster presentations, is intended to maximize a thought-provoking flow of information and discourse among scientists.

Program Information

Click on the day/date to expand or contract the schedule:

Programming for Tuesday, May 5
TIMEEVENT
7:00 a.m. – 8:00 a.m.Early Career Training
Organized in cooperation with the ATVB Early Career Committee
8:30 a.m. – 10:00 a.m.Plenary Session I: From Discovery to Therapeutics – How Basic Science Can Help to Address Unmet Clinical Needs in Cardiovascular Medicine
  • Presentation Title TBD, Eric Olson, PhD, Dallas, Texas
  • Antisense Oligonucleotides for the Treatment of Cardio-Metabolic Diseases, Roseanne M. Crooke, PhD, Boston, Massachusetts
  • Altered Genes Triggering Acute Aortic Dissections Implicate Mechanotransduction as a Primary Driver of the Disease, Dianna M. Milewicz, MD, PhD, Houston, Texas
10:00 a.m. – 10:30 a.m.Break and Exhibits
10:30 a.m. – 12:15 p.m.

Concurrent Session I A: Molecular and Cellular Mechanisms of Atherosclerosis
Presentation Title TBD, Chiara Giannarelli, MD, PhD, New York, New York
Oral Abstract Presentations

Concurrent Session I B: Molecular, Developmental and Cellular Biology of the Vessel Wall
Clonal Vascular Smooth Muscle Cell Expansion in Disease, Helle F. Jørgensen, PhD, Cambridge, United Kingdom
Oral Abstract Presentations

Concurrent Session I C: Translational Science of Vascular Medicine: Emerging Research in Thrombosis and Hemostasis
Organized in cooperation with the Council on Peripheral Vascular Disease

Presenter TBD
Oral Abstract Presentations

12:15 p.m. – 2:15 p.m.Next-Generation Technology Bootcamp: Data Science

The Mentor of Women Award Luncheon

PVD Annual Business Meeting and Networking Luncheon

Or lunch on your own
2:15 p.m. – 3:45 p.m.Plenary Session II:  Highlights from the ATVB Journal

  • ATVB Journal Report, Alan Daugherty, PhD, DSc, FAHA, Lexington, KY
  • Presentations by the 2020 ATVB Journal Early Career Investigator Award Recipients
  • Hemostasis and Thrombosis – Two Sides of the Same Coin, Nigel Mackman, PhD, FAHA, Chapel Hill, North Carolina
3:45 p.m. – 4:15 p.m.Break and Exhibits
4:15 p.m. – 6:00 p.m.

Concurrent Session II A: Lipoproteins and Lipid Metabolism: LDL and Beyond
Endothelial Cell Lipoprotein Transport and Atherosclerosis, Philip W. Shaul, MD, Dallas, Texas
Oral Abstract Presentations

Concurrent Session II B: Vascular Immunity, Inflammation and Thrombosis
Organized in cooperation with the European Society of Cardiology
Immune Cell Communication in Atherosclerosis, Esther Lutgens, MD, PhD, Amsterdam, Netherlands
Oral Abstract Presentations

Concurrent Session II C: Translational Science in Vascular Medicine: Bioengineered Stents and Conduits
Organized in cooperation with the Council on Peripheral Vascular Disease
Molecular Engineering of Angiogenenic Growth Factors, Jeffrey A. Hubbell, PhD, Chicago, Illinois
Oral Abstract Presentations

6:00 p.m. – 8:00 p.m.Poster Session and Reception

Programming for Wednesday, May 6
TIMEEVENT
7:00 a.m. – 8:00 a.m.Early Career Training
Organized in cooperation with the ATVB Early Career Committee
8:30 a.m. – 9:30 a.m.Plenary Session III:  Multiomics in Cardiovascular Science
  • Multi-tissue Multi-omics Approaches to Cardiovascular Diseases, Xia Yang, PhD, Los Angeles, California
  • Human Knockout Project, Danish Saleheen, MBBS, PhD, Philadelphia, Pennsylvania
  • Combined Germline and Somatic Genetic Analysis for Atherosclerotic Cardiovascular Disease, Pradeep Natarajan, MD, MMSc, Boston, Massachusetts
9:30 a.m. – 10:00 a.m.Break and Exhibits
10:30 a.m. – 11:45 a.m.

Concurrent Session III A:  Therapeutic Targets in Atherosclerosis
Presenter TBD
Oral Abstract Presentations

Concurrent Session III B:  Blood Coagulation and Antithrombotic Therapy
Presentation Title TBD, Maureane Hoffman, MD, PhD, Durham, North Carolina
Oral Abstract Presentations

Concurrent Session III C:  Translational Science in Vascular Medicine: Vascular Dysfunction
Organized in cooperation with the Council on Peripheral Vascular Disease
Presentation Title TBD, Sanjay Misra, MD, Rochester, Minnesota
Rapid Fire Oral Abstract Presentations

11:45 a.m. – 1:45 p.m.Next-Generation Technology Bootcamp: Single Cell Sequencing

Or lunch on your own
1:45 p.m. – 3:45 p.m.Plenary Session IV:  Award Competition
  • Kenneth M. Brinkhous Early Career Investigator Prize in Thrombosis
  • Irvine H. Page Junior Faculty Research Award
3:45 p.m. – 4:15 p.m.Break and Exhibits
4:15 p.m. – 6:00 p.m.

Concurrent Session IV A:  Metabolic Disorders and Atherosclerosis
Presentation Title TBD, Catherine C. (Lynn) Hedrick, PhD, La Jolla, California
Oral Abstract Presentations

Concurrent Session IV B:  Platelet Production, Signaling and Function
Platelet-TLR7 Function: The Crossroad of Immunity and Thrombosis, Milka Koupenova, PhD, Worcester, Massachusetts
Oral Abstract Presentations

Concurrent Session IV C:  Translational Aspects of Aortic Aneurysm Disease
Presentation Title TBD, Ronald L. Dalman, MD, Stanford, California
Oral Abstract Presentations

6:00 p.m. – 8:00 p.m.Poster Session and Reception
8:00 p.m. – 10:30 p.m.Joint Council Dinner (ticket required)

Programming for Thursday, May 7
TIMEEVENT
7:00 a.m. – 8:30 a.m.Early Career Training: Grant Writing Workshop
Organized in cooperation with the ATVB and PVD Early Career Committees
8:30 a.m. – 10:30 a.m.Poster Session and Continental Breakfast
10:30 a.m. – Noon

Plenary Session V:  Invited Lecture Series

  • Jeffrey M. Hoeg Arteriosclerosis, Thrombosis and Vascular Biology Award for Basic Science and Clinical Research Lecture
    TBD
     
  • Keynote Lecture
    Exploring Resilience to Cardiovascular Insults, Louisa Iruela-Arispe, PhD, Chicago, Illinois
     
  • Distinguished Lecture
    Network Medicine, Systems Pharmacology, and Cardiovascular Drug Development, Joseph Loscalzo, MD, PhD, Boston, Massachusetts

Closing Remarks/Conference Adjourns

Target Audience

The conference will especially appeal to:
  • Basic scientists
  • Translational and clinical investigators
  • Clinicians interested in:
Target Audience - Clinicians interested in:
Vascular HealthVascular Medicine
AtherosclerosisVascular Biology
ThrombosisVascular surgery
ThromboembolismPeripheral artery disease
Molecular/cellular biologyFunctional genomics
Tools for Presenters

Reminder: All abstract presenters must register for the conference in order to present their research.